GSK & AN2 Partner on Boron-Based LeuRS Inhibitors for TB
10 Nov 2025 //
BUSINESS WIRE
AN2 Therapeutics Joins Fireside Chat At Evercore HealthCONx
06 Nov 2025 //
BUSINESS WIRE
TAE Life BNCT Drugs + ICI Show Tumor Inhibition in Preclinical
29 Sep 2025 //
BUSINESSWIRE
AN2 Therapeutics Reports Phase 3 Data from EBO-301 Study
01 May 2025 //
BUSINESSWIRE
Incheon National University Scientists Review Progress in Anticancer Compounds
26 Jan 2022 //
PRNEWSWIRE

Market Place
Sourcing Support